Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis — United States, 2025
by from Morbidity and Mortality Weekly Report (MMWR) on (#704NV)
This report describes a clinical recommendation to use injectable lenacapavir as an HIV preexposure prophylaxis.